Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets, Mayzent 1 mg film-coated tablets, BAF312, BAF312, BAF312
SIPO20
Approved small_molecule active
Quick answer
Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets, Mayzent 1 mg film-coated tablets, BAF312, BAF312, BAF312 for Active progressive multiple sclerosis course after an initial relapse clinical course is a Approved program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Verona Pharma Ireland Limited
- Indication
- Active progressive multiple sclerosis course after an initial relapse clinical course
- Phase
- Approved
- Modality
- small_molecule
- Status
- active